Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Centrica PLC Board/Management Information 2024

Dec 16, 2024

5292_mang_2024-12-16_25b875ef-bb1c-4e6a-8c7a-c65f5652a6b6.html

Board/Management Information

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

RNS Number : 1281Q

Centrica PLC

16 December 2024

16 December 2024

Centrica plc

('Centrica' or 'the Company')

Centrica plc Director Update

Further to its announcements of 25 July 2024 and 14 November 2024, Centrica confirms that Kevin O'Byrne succeeds Scott Wheway as Chair and Jo Harlow assumes the role of Senior Independent Director with effect from today. 

Pursuant to those announcements and Listing Rule 6.4.6R, Centrica also confirms that Scott Wheway is standing down from the Board today.

Kevin O'Byrne said:

"On behalf of the Board I would like to thank Scott for his significant contribution, insights and commitment to Centrica since his initial appointment as a director in 2016."

Notes

1.            Following his appointment as Chair, Kevin O'Byrne has stepped down as a member of the Audit and Risk Committee and will be appointed as Chair of the Nominations Committee with immediate effect.

Enquiries:

Investors and Analysts

T: 01753 494900

E: [email protected]

Media

T: 01784 843000

E: [email protected]

Centrica plc is listed on the London Stock Exchange (CNA)

Registered Office: Millstream, Maidenhead Road, Windsor, Berkshire SL4 5GD

Registered in England & Wales number: 3033654

Legal Entity Identifier number: E26EDV109X6EEPBKVH76

ISIN number: GB00B033F229

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BOATABBTMTJBBTI